Improvement in Uroflowmetry Parameters After Transurethral Resection of Prostate for Bladder Outlet Obstruction in Benign Prostatic Hyperplasia
Uroflowmetry Outcomes After TURP in BPH
DOI:
https://doi.org/10.54393/pjhs.v7i9.4091Keywords:
Benign Prostatic Hyperplasia, TURP, Uroflowmetry, IPSS, Bladder Outlet ObstructionAbstract
Benign prostatic hyperplasia (BPH) commonly causes bladder outlet obstruction and lower urinary tract symptoms in older men. Transurethral resection of the prostate (TURP) is a standard surgical option, but the outcome should be assessed objectively. Objectives: To determine changes in uroflowmetry parameters and International Prostate Symptom Score (IPSS) after TURP in BPH. Methods: This prospective before-and-after interventional study was conducted at the Multan Institute of Kidney Diseases, Multan, from February to May 2026. Forty-five consecutive men undergoing TURP for BPH were enrolled. Qmax, Qavg, voided volume, voiding time, time to maximum flow, post-void residual urine (PVR), and IPSS were recorded before surgery and four weeks postoperatively. Paired t-test and McNemar test were applied. Results: Mean age was 67.98 ± 7.18 years, and mean prostate volume was 65.87 ± 17.16 mL. After TURP, Qmax increased from 8.08 ± 1.58 to 19.87 ± 2.35 mL/s and Qavg from 4.32 ± 0.84 to 10.64 ± 1.57 mL/s. PVR decreased from 157.69 ± 41.90 to 37.16 ± 16.10 mL, and IPSS from 24.13 ± 3.96 to 8.20 ± 2.35. All changes were significant (p<0.001). Severe IPSS category decreased from 36 (80.0%) cases to 0, and all patients converted from obstructed to normal flow patterns. Conclusions: TURP significantly improved flow parameters, residual urine, symptom severity, and flow pattern. Uroflowmetry with IPSS is useful for postoperative assessment.
References
Zekraoui O, Bhojani N, Zorn KC, Elterman D, Chughtai B. Management and Treatment of Benign Prostatic Hyperplasia Symptoms: Current Insights. Research and Reports in Urology. 2025 Dec; 31: 401-20. doi:10.2147/RRU.S510367. DOI: https://doi.org/10.2147/RRU.S510367
Memon AH, Chandio MA, Bhellar ZH, Rehman HU, Akhtar S, Bhurt A. Role of Uroflowmetry in Patients of Benign Prostatic Hyperplasia Presenting with Lower Urinary Tract Symptoms: Uroflowmetry in Benign Prostatic Hyperplasia. Pakistan Journal of Health Sciences. 2024 Nov; 30: 40-5. doi: 10.54393/pjhs.v5i11.2409. DOI: https://doi.org/10.54393/pjhs.v5i11.2409
Sinha S. The Use of Uroflowmetry as a Diagnostic Test. Current Urology Reports. 2024 May; 25(5): 99-107. doi: 10.1007/s11934-024-01200-0. DOI: https://doi.org/10.1007/s11934-024-01200-0
Almas F, Dasdelen MF, Seyhan Z, Sargolzaeimoghaddam M, Sarg A, Unlu O et al. Reassessing Normal Voiding Standards: A Cross-Sectional Study Based on Medical Professionals’ Evaluations with Portable Uroflowmetry and International Prostate Symptom Score. Journal of Clinical Medicine. 2024 May; 13(10): 2857. doi: 10.3390/jcm13102857. DOI: https://doi.org/10.3390/jcm13102857
Sandhu JS, Bixler BR, Dahm P, Goueli R, Kirkby E, Stoffel JT et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: American Urological Association guideline amendment 2023. The Journal of Urology. 2024 Jan; 211(1): 11-9. doi: 10.1097/JU.0000000000003698. DOI: https://doi.org/10.1097/JU.0000000000003698
Baboudjian M, Hashim H, Bhatt N, Creta M, De Nunzio C, Gacci M et al. Summary Paper on Underactive Bladder from the European Association of Urology Guidelines on Non-Neurogenic Male Lower Urinary Tract Symptoms. European Urology. 2024 Sep; 86(3): 213-20. doi: 10.1016/j.eururo.2024.04.004. DOI: https://doi.org/10.1016/j.eururo.2024.04.004
Oranusi CK, Nwofor AE, Mbonu O. Correlation Between International Prostate Symptom Score and Uroflowmetry in Patients with Benign Prostatic Hyperplasia. Nigerian Journal of Clinical Practice. 2017 Apr; 20(4): 454-8. doi: 10.4103/1119-3077.196120. DOI: https://doi.org/10.4103/1119-3077.196120
Murad L, Bouhadana D, Nguyen DD, Chughtai B, Zorn KC, Bhojani N et al. Treating Lower Urinary Tract Symptoms in Men with Benign Prostatic Obstruction: A Review Article: L. Murad et al. Drugs and Aging. 2023 Sep; 40(9): 815-36. doi: 10.1007/s40266-023-01054-0. DOI: https://doi.org/10.1007/s40266-023-01054-0
Mani V, Korrapati B, Palaniyandi V, Sekar H, Krishnamoorthy S. Effectiveness of Transurethral Resection of the Prostate in Managing Lower Urinary Tract Symptoms and Enhancing Quality of Life: A Prospective South Indian Study. Cureus. 2025 Aug; 17(8): 1-9. doi: 10.7759/cureus.90945. DOI: https://doi.org/10.7759/cureus.90945
Ito H, Sakamaki K, Young GJ, Blair PS, Hashim H, Lane JA et al. Predicting Prostate Surgery Outcomes from Standard Clinical Assessments of Lower Urinary Tract Symptoms to Derive Prognostic Symptom and Flowmetry Criteria. European Urology Focus. 2024 Jan; 10(1): 197-204. doi: 10.1016/j.euf.2023.06.013. DOI: https://doi.org/10.1016/j.euf.2023.06.013
Zou P, Liu C, Zhang Y, Wei C, Liu X, Xu S et al. Transurethral Surgical Treatment for Benign Prostatic Hyperplasia with Detrusor Underactivity: A Systematic Review and Meta-Analysis. Systematic Reviews. 2024 Mar; 13(1): 93. doi: 10.1186/s13643-024-02514-3. DOI: https://doi.org/10.1186/s13643-024-02514-3
Nadeem R, Siddique MH, Zehra NU, Aziz W, Ather H. Comparative Safety and Short-Term Effectiveness of Monopolar Transurethral Resection Enucleation of the Prostate in Enlarged Prostate. Journal of the College of Physicians and Surgeons--Pakistan. 2026 Jun; 36(6): 767-73. doi: 10.29271/jcpsp.2026.06.767. DOI: https://doi.org/10.29271/jcpsp.2026.06.767
Porto JG, Bhatia AM, Bhat A, Suarez Arbelaez MC, Blachman-Braun R, Shah K et al. Evaluating Transurethral Resection of the Prostate Over Twenty Years: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. World Journal of Urology. 2024 Nov; 42(1): 639. doi: 10.1007/s00345-024-05332-3. DOI: https://doi.org/10.1007/s00345-024-05332-3
Song SH, Chung Y, Ryu H, Lee JW, Lee S. Efficacy and Reliability of Mobile Uroflowmetry in Patients with Benign Prostatic Hyperplasia Undergoing Transurethral Resection: Prospective Multicenter Observational Pilot Validation Study. Journal of Medical Internet Research. 2025 Dec; 27: e75313. doi: 10.2196/75313. DOI: https://doi.org/10.2196/75313
Sharma G, Agarwal BK, Mendiratta P, Sagar SK. To Compare Uroflowmetric Parameters in Benign Prostatic Hyperplasia Pre and Post Trans Urethral Resection of the Prostate. SRMS Journal of Medical Science. 2024 Dec; 9(02): 91-4.
Ngalle FG, Makon AS, Essomba AQ, Bessala DS, Essoh J, Herve MM. Impact of Transurethral Resection of the Prostate on Urodynamic Parameters in a Developing Country. Environment. 2025; 19: 20.
Acharya M, Dhamala I, Bhatta S, Sapkota K, Mishra D, Tandan S et al. Prospective Analysis of Uroflowmetric Changes After Transurethral Resection of the Prostate. Single-Anastomosis Sleeve Journal of Surgery. 2025 Dec; 12: 1130-7. doi: 10.36347/sasjs.2025.v11i12.013. DOI: https://doi.org/10.36347/sasjs.2025.v11i12.013
Bansal N and Adiga P. Comparative Study of Uroflowmetric Parameters Pre- and Post-TURP in Benign Prostatic Hyperplasia. Journal. Urological and Renal Diseases. 2023; 8: 1314. DOI: https://doi.org/10.29011/2575-7903.001314
Khalil MA, Abbasi S, Nawaz R, Rashid NU, Ghazi MA, Patujo YH et al. Therapeutic Efficacy and Complication Profile of Monopolar Transurethral Resection of the Prostate (TURP) in the Management of Bladder Outlet Obstruction. Cureus. 2025 Aug; 17(8). doi: 10.7759/cureus.89640. DOI: https://doi.org/10.7759/cureus.89640
Sahu S, Parmar K, Kumar S, Tyagi S, Mandal S, Devana SK et al. Effect of Transurethral Resection of the Prostate on Urodynamic Parameters in Patients with Benign Prostatic Enlargement with Upper Urinary Tract Dilatation. Urologia Internationalis. 2021 Sep; 105(9-10): 846-51. doi: 10.1159/000515989. DOI: https://doi.org/10.1159/000515989
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2026 Pakistan Journal of Health Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments



